Hanson & Doremus Investment Management

Position in HLN — Haleon plc

CIK 1393944 BURLINGTON, VT

Back to HLN Full portfolio

Position in HLN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$9,721

-$689 QoQ

Shares Held

1,042

+0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#476

of 639 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in HLN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Hanson & Doremus Investment Management holds $380,323 across 4 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	15,161	$219,682
2	ZTS	Zoetis Inc.	2,079	$149,396
3	HLN	Haleon plc This page	1,042	$9,721
4	VTRS	Viatris Inc	96	$1,524

All Filings in HLN

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,721	1,042	+0.2%	Shares	Sole	2026-07-29
2026-03-31	$10,410	1,040	0.0%	Shares	Sole	2026-04-17
2025-12-31	$10,514	1,040	0.0%	Shares	Sole	2026-01-20
2025-09-30	$9,328	1,040	-56.2%	Shares	Sole	2025-10-15
2025-06-30	$24,597	2,372	+234.1%	Shares	Sole	2025-07-17
2025-03-31	$7,305	710	—	Shares	Sole	2025-04-17
No filing history on record for this holder in this stock.